L

Lotus Pharmaceutical
1795

Last Price

Lotus Pharmaceutical Cash Flow Statement

Operating Activities
Metric20092010201120122013201420152016201720182019202020212022202320242025
NT$6.36BNT$5.718B
NT$1.283BNT$1.536B
--
NT$348.649MNT$279.377M
NT$-0.712BNT$1.758B
NT$-1.125BNT$-1.809B
NT$6.155BNT$7.482B
Investing Activities
Metric20092010201120122013201420152016201720182019202020212022202320242025
NT$-0.354BNT$-1.32B
NT$-1.241BNT$-8.134B
--
--
NT$-1.096BNT$-3.014B
NT$-2.691BNT$-12.468B
Financing Activities
Metric20092010201120122013201420152016201720182019202020212022202320242025
NT$2.058BNT$9.304B
NT$0.259MNT$-775.79M
NT$-1.232BNT$-1.52B
NT$-112.495MNT$-112.502M
NT$0.714BNT$6.896B
Cash Position
Metric20092010201120122013201420152016201720182019202020212022202320242025
NT$1.771BNT$6.03B
NT$4.259BNT$1.71B
NT$6.03BNT$7.74B
NT$6.155BNT$7.482B
NT$-1.466BNT$-4.355B
NT$4.689BNT$3.127B

Cash Flow Statement Waterfall

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.